Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by SageView Advisory Group LLC

SageView Advisory Group LLC lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 31.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 2,843 shares of the medical equipment provider's stock after selling 1,299 shares during the quarter. SageView Advisory Group LLC's holdings in Intuitive Surgical were worth $1,396,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of ISRG. Massachusetts Financial Services Co. MA bought a new position in shares of Intuitive Surgical during the 3rd quarter valued at approximately $558,807,000. International Assets Investment Management LLC boosted its holdings in Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider's stock valued at $535,788,000 after acquiring an additional 1,088,415 shares during the period. FMR LLC boosted its holdings in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock valued at $5,389,765,000 after acquiring an additional 838,793 shares during the period. Strategic Financial Concepts LLC boosted its holdings in Intuitive Surgical by 40,221.4% during the 2nd quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider's stock valued at $1,184,000 after acquiring an additional 265,461 shares during the period. Finally, Assenagon Asset Management S.A. boosted its holdings in Intuitive Surgical by 15.4% during the 2nd quarter. Assenagon Asset Management S.A. now owns 1,483,406 shares of the medical equipment provider's stock valued at $659,893,000 after acquiring an additional 197,841 shares during the period. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Trading Up 0.5 %

Shares of ISRG traded up $2.76 during trading hours on Friday, hitting $550.41. The company had a trading volume of 1,026,203 shares, compared to its average volume of 1,445,625. The company has a market capitalization of $196.04 billion, a PE ratio of 88.49, a price-to-earnings-growth ratio of 5.33 and a beta of 1.38. Intuitive Surgical, Inc. has a one year low of $307.72 and a one year high of $556.23. The company's fifty day moving average price is $514.78 and its two-hundred day moving average price is $472.60.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on ISRG. Stifel Nicolaus boosted their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a report on Thursday. Leerink Partners boosted their price objective on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Citigroup boosted their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a "buy" rating in a report on Thursday, August 22nd. Mizuho upped their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $495.00 to $575.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $541.33.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 238 shares of the stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $477.50, for a total value of $113,645.00. Following the transaction, the executive vice president now directly owns 5,506 shares of the company's stock, valued at approximately $2,629,115. This represents a 4.14 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, General Counsel Gary Loeb sold 300 shares of the stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the transaction, the general counsel now directly owns 1,595 shares in the company, valued at $757,625. This represents a 15.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 51,023 shares of company stock valued at $26,384,247 in the last ninety days. Corporate insiders own 0.90% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.